[New-onset trichotillomania during treatment with stimulant drugs. About two pediatric clinical cases].

Autor:	Fernández Manso B; Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España. bfmanso_21@hotmail.com., Villora Morcillo N; Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España., Taboas Pereira MA; Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España., Elipe Maldonado C; Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España.
Jazyk:	Spanish; Castilian
Zdroj:	Archivos argentinos de pediatria [Arch Argent Pediatr] 2020 Feb; Vol. 118 (1), pp. e61-e62.
DOI:	10.5546/aap.2020.e61
Abstrakt:	Stimulant drugs are commonly used in pediatric population in the treatment of attention deficit hyperactivity disorder, and their side effects are well described, however trichotillomania does not appear as one of them. In the literature we found some published cases of trichotillomania in relation to methylphenidate and dextroamphetamine. We present two cases of new-onset trichotillomania in children followed up in our center by attention deficit hyperactivity disorder and treated with psychostimulant drugs (methylphenidate and lisdexamfetamine), as a probable adverse effect of this treatment. Competing Interests: The authors report no conflicts of interest in this work. (Sociedad Argentina de Pediatría.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu